Advertisement

Clinical & Experimental Metastasis

, Volume 7, Issue 5, pp 571–584 | Cite as

Detection of metastasis-associated differences for receptors of glycoconjugates (lectins) in histomorphologically unchanged xenotransplants from primary and metastatic lesions of human colon adenocarcinomas

  • Hans -Joachim Gabius
  • Thomas Ciesiolka
  • Ekkehard Kunze
  • Katalin Vehmeyer
Article

Abstract

Clinically applicable markers for tumor progression may be uncovered by selective analysis of biochemical parameters, supposedly participating in this complex process. Owing to the importance of specific protein-carbohydrate interactions in diverse biological processes, the pattern of the receptor part in this glycobiochemical recognition system, the sugar receptors (lectins), conceivably reflects biological properties of tumor cells in glycobiochemical terms. Therefore, we established and characterized xenografts from surgically removed specimens of a human primary colon adenocarcinoma and its metastatic lesions to liver of the same patient and of a histomorphologically similar primary colon adenocarcinoma of another patient in nude mice. Xenotransplantation and subsequent glycobiochemical analysis of material from early passages with a standardized procedure had been preferred to cell culture in monolayer on account of maintenance of a higher degree of organized histotypic assembly. Despite histomorphological similarities, the sugar receptor profile revealed significant differences in tumor-tumor and tumor-metastasis comparison, especially forα -and β-galactoside-binding proteins. Tumor-metastasis differences were substantiated by a second successfully xenotransplanted pair of specimens. Comprehensive expansion of these initial data may eventually lead to desirable functional correlations with the different biological properties of histomorphologically similar primary colon adenocarcinomas and of the metastatic phenotype and to a rational development of therapeutic modalities to restrict tumor growth and spread.

Keywords

Nude Mouse Biological Property Human Colon Metastatic Lesion Recognition System 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    August, D. A., Ottow, R. T., andSugarbaker, P. H., 1984, Clinical perspectives of human colorectal cancer metastasis.Cancer and Metastasis Reviews,3, 303–325.PubMedGoogle Scholar
  2. [2]
    Blum, H., Beier, H., andGross, H. J., 1987, Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels.Electrophoresis,8, 93–99.Google Scholar
  3. [3]
    Bresalier, R. S., Boland, C. R., andKim, Y. S., 1984, Characteristics of colorectal carcinoma cells with high metastatic potential.Gastroenterology,87, 115–122.PubMedGoogle Scholar
  4. [4]
    Carding, S. R., Thorpe, S. J., Thorpe, R., andFeizi, T., 1985, Transformation and growth related changes in levels of nuclear and cytoplasmic proteins antigenically related to mammalian β-galactoside-binding lectin.Biochemical and Biophysical Research Communications,127, 680–686.PubMedGoogle Scholar
  5. [5]
    Ciesiolka, T., andGabius, H. J., 1988, An eight-to ten-fold enhancement in sensitivity for quantitation of proteins by modified application of colloidal gold.Analytical Biochemistry,168, 280–283.PubMedGoogle Scholar
  6. [6]
    Damjanov, I., 1987, Lectin cytochemistry and histochemistry.Laboratory Investigation,57, 5–20.PubMedGoogle Scholar
  7. [7]
    Dennis, J. W., andLaferte, S., 1987, Tumor cell surface carbohydrate and the metastatic phenotype.Cancer and Metastasis Reviews,5, 185–204.PubMedGoogle Scholar
  8. [8]
    Feizi, T., 1985, Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are onco-developmental antigens.Nature (London),314, 53–57.Google Scholar
  9. [9]
    Fidler, I. J., andPoste, G., 1985, The cellular heterogeneity of malignant neoplasms: implications for adjuvant chemotherapy.Seminars in Oncology,12, 207–221.PubMedGoogle Scholar
  10. [10]
    Fidler, I. J., andBalch, C.M., 1987, The biology of cancer metastasis and implications for therapy.Current Problems in Surgery,24, 137–209.Google Scholar
  11. [11]
    Gabius, H. J., 1987, Endogenous lectins in tumors and the immune system.Cancer Investigation,5, 39–46.PubMedGoogle Scholar
  12. [12]
    Gabius, H. J., 1988, Mammalian lectins: their structure and their glycobiological and glycoclinical roles.ISI Atlas of Science: Biochemistry,1, 210–214.Google Scholar
  13. [13]
    Gabius, H. J., 1988, Tumorlektinologie: ein Gebiet im Schnittpunkt von Zuckerchemie, Biochemie, Zellbiologie und Onkologie.Angewandte Chemie,100, 1321–1330; Tumourlectinology: at the intersection of carbohydrate chemistry, biochemistry, cell biology and oncology.Angewandte Chemie, International Edition in English,27, 1267–1276.Google Scholar
  14. [14]
    Gabius, H. J., 1989, Potential participation of tumor lectins in cancer diagnosis, therapy and biology.Advances in Lectin Research, in press.Google Scholar
  15. [15]
    Gabius, H. J., 1988, Targeting of neoglycoprotein-drug conjugates to human tumor cells via endogenous lectins.Annals of the New York Academy of Sciences,507, 337–338.Google Scholar
  16. [16]
    Gabius, H. J., andEngelhardt, R., 1988, Sugar receptors of different types in human metastases to lung and liver.Tumor Biology,9, 21–36.PubMedGoogle Scholar
  17. [17]
    Gabius, H. J., andNagel, G. A. (Eds), 1988,Lectins and Glycoconjugates in Oncology (Heidelberg: Springer Verlag).Google Scholar
  18. [18]
    Gabius, H. J., andVehmeyer, K., 1988, Effect of microenvironmentand cell lineage type on carbohydrate-binding proteins of macrophage-like cells.Biochemistry Cell Biology,66, 1169–1176.Google Scholar
  19. [19]
    Gabius, H. J., Engelhardt, R., Rehm, S., andCramer, F., 1984, Biochemical characterization of endogenous carbohydrate-binding proteins from spontaneous murine rhabdomyosarcoma, mammary adenocarcinoma, and ovarian teratoma.Journal of the National Cancer Institute,73, 1349–1357.PubMedGoogle Scholar
  20. [20]
    Gabius, H. J., Engelhardt, R., Cramer, F., Bätge, R., andNagel, G. A., 1985, Pattern of endogenous lectins in a human epithelial tumor.Cancer Research,45, 253–257.PubMedGoogle Scholar
  21. [21]
    Gabius, H. J., Engelhardt, R., Rehm, S., Deerberg, F., andCramer, F., 1986, Differences in the pattern of endogenous lectins from spontaneous rat mammary tumors.Tumour Biology,7, 71–81.PubMedGoogle Scholar
  22. [22]
    Gabius, H. J., Bodanowitz, S., andSchauer, A., 1988, Endogenous sugar-binding proteins in human breast tissue and benign and malignant breast lesions.Cancer,61, 1125–1131.PubMedGoogle Scholar
  23. [23]
    Gunderson, L. L., Beart, R. W., andO'Connell, M. J., 1987, Current issues in the treatment of colorectal cancer.CRC Critical Reviews in Oncology/Hematology,6, 223–260.Google Scholar
  24. [24]
    Irimura, T., Ota, D. M., andCleary, K. R., 1987,Ulex europaeus agglutinin I-reactive high molecular weight glycoproteins of adenocarcinoma of distal colon and rectum and their possible relationship with metastatic potential.Cancer Research,47, 881–889.PubMedGoogle Scholar
  25. [25]
    Kahn, H. J., andBaumal, R., 1985, Differences in lectin binding in tissue sections of human and murine malignant tumors and their metastases.American Journal of Pathology,119, 420–429.PubMedGoogle Scholar
  26. [26]
    Kellokumpu, I. H., 1986, Differences in lectin reactivities of cellular glycoconjugates between primary human colorectal carcinomas and their metastases.Cancer Research,46, 4620–4625.PubMedGoogle Scholar
  27. [27]
    Kim, Y. S., Yuan, M., Itzkowitz, S. H., Sum, Q., Kaizu, T., Palekar, A., Trump, B. F., andHakomori, S. I., 1986, Expression of LeY and extended LeY blood group-related antigens in human malignant, premalignant and nonmalignant colonic tissues.Cancer Research,46, 5985–5992.PubMedGoogle Scholar
  28. [28]
    Lotan, R., Lotan, D., andRaz, A., 1985, Inhibition of tumor cell colony formation in culture by a monoclonal antibody to endogenous lectins.Cancer Research,45, 4349–4353.PubMedGoogle Scholar
  29. [29]
    Lotan, R., andRaz, A., 1988, Endogenous lectins as mediators of tumor cell adhesion.Journal of Cellular Biochemistry,37, 107–117.PubMedGoogle Scholar
  30. [30]
    Moutsatsos, I. K., Wade, M., Schindler, M., andWang, J. L., 1987, Endogenous lectins from cultured cells: nuclear localization of carbohydrate-binding protein 35 in proliferating 3T3 fibroblasts.Proceedings of the National Academy of Sciences of the USA,84, 6452–6456.PubMedGoogle Scholar
  31. [31]
    Nicolson, G. L., 1982, Cancer metastasis: organ colonization and the cell surface properties of malignant cells.Biochimica et Biophysica Acta,695, 113–176.PubMedGoogle Scholar
  32. [32]
    Nicolson, G. L., 1984, Cell surface molecules and tumor cell metastasis.Experimental Cell Research,150, 3–22.PubMedGoogle Scholar
  33. [33]
    Ochs, D., 1983, Protein contaminants of sodium dodecyl sulfate-polyacrylamide gels.Analytical Biochemistry,135, 470–474.PubMedGoogle Scholar
  34. [34]
    Osborn, M., andWeber, K., 1982, Immunofluorescence and immunocytochemical procedures with affinity purified antibodies: tubulin-containing structures.Methods in Cell Biology,24, 97–132.PubMedGoogle Scholar
  35. [35]
    Schirrmacher, V., Altevogt, P., Fogel, M., Dennis, J., Waller, C. A., Barz, D., Schwartz, R., Cheingsong-Popov, R., Springer, G., Robinson, P. J., Nebe, T., Brossmer, W., Vlodavsky, I., Paweletz, N., Zimmermann, H. P., andUhlenbruck, G., 1982, Importance of cell surface carbohydrates in cancer cell adhesion, invasion and metastasis.Invasion and Metastasis,2, 313–360.Google Scholar
  36. [36]
    Schirrmacher, V., 1985, Cancer metastasis: experimental approaches, theoretical concepts, and impact for treatment strategies.Advances in Cancer Research,43, 1–73.PubMedGoogle Scholar
  37. [37]
    Schoentag, R., Primus, F. J., andKuhns, W., 1987, ABH and Lewis blood group expression in colorectal carcinoma.Cancer Research,47, 1695–1700.PubMedGoogle Scholar
  38. [38]
    Seve, A. P., Hubert, J., Bouvier, D., Bourgeois, C., Midoux, P., Roche, A. C., andMonsigny, M., 1986, Analysis of suger-binding sites in mammalian cell nuclei by quantitative flow microfluorometry.Proceedings of the National Academy of Sciences of the USA,85, 5997–6001.Google Scholar
  39. [39]
    Spremulli, E. N., andDexter, D. L., 1983, Human tumor cell heterogeneity and metastases.Journal of Clinical Oncology,1, 496–509.PubMedGoogle Scholar
  40. [40]
    Tarin, D., 1985, Clinical and experimental studies on the biology of metastasis.Biochimica et Biophysica Acta,780, 227–235.PubMedGoogle Scholar
  41. [41]
    Vehmeyer, K., Hajto, T., andGabius, H. J., 1988, Immunomodulation by endogenous β-galactoside-specific lectins. In:Lectins and Glycoconjugates in Oncology, edited by H. J. Gabius and G. A. Nagel (Heidelberg: Springer), pp. 207–211.Google Scholar
  42. [42]
    Warren, L., Fuhrer, J. P., andTusgynski, G. P., 1978, Glycopeptide changes and malignant transformation: a possible role for carbohydrates in malignant behavior.Biochimica et Biophysica Acta,516, 97–127.PubMedGoogle Scholar
  43. [43]
    Weiss, L., 1985,Principles of Metastasis (Orlando: Academic Press).Google Scholar
  44. [44]
    Yamamura, M., Hamada, Y., Kogata, M., Kiba, M., Uetsuji, S., Yamamoto, M., andAdachi, M., 1985, Postoperative immunization with peanut agglutinin-binding glycoprotein from Lewis lung carcinoma in mice.Journal of Surgical Research,38, 39–44.PubMedGoogle Scholar
  45. [45]
    Yogeeswaran, G., 1983, Cell surface glycolipids and glycoproteins in malignant transformation.Advances in Cancer Research,38, 289–350.PubMedGoogle Scholar

Copyright information

© Taylor & Francis Ltd 1989

Authors and Affiliations

  • Hans -Joachim Gabius
    • 1
  • Thomas Ciesiolka
    • 1
  • Ekkehard Kunze
    • 2
  • Katalin Vehmeyer
    • 3
  1. 1.Abteilung Chemie, Max-Planck-Institut für experimentelle MedizinGöttingen
  2. 2.Zentrum Pathologie der UniversitätGöttingen
  3. 3.Abteilung Hämatologie-OnkologieMedizinische UniversitätsklinikGöttingenFederal Republic of Germany

Personalised recommendations